Intranasal Administration of IL-27 Pre-OVA Sensitization Alleviate Allergic Airway Inflammation in Mice Model

Zhihong Chen,Xiaoqiong Su,Nian Dong,Kan Xu,Xiangdong Wang

DOI: https://doi.org/10.1016/j.chest.2016.02.031

IF: 9.6

2016-01-01

Chest

Abstract:SESSION TITLE: Asthma III SESSION TYPE: Original Investigation Poster PRESENTED ON: Saturday, April 16, 2016 at 11:45 AM - 12:45 PM PURPOSE: IL-27 is a family member of Th1 type cytokines, which could promote Th1 development and inhibit Th2 and Th17 development as well. Asthma is Th2-prone chronic airway inflammation. In this study, animal models were set up to observe whether IL-27 intervention could diminish allergic airway inflammation and to investigate the related molecular mechanisms. METHODS: Two IL-27 intervention ways were set up, one of which is low-dose-multiple preventive model, the other is high-dose-few times treating model. Airway hyperresponsiveness BAL, HE staining were tested. The mRNA, protein level of STAT1 and GADD45γ were measured through qPCR and western blot. RESULTS: In asthma model, both STAT1 phosphorylation and GADD45γ expression which mediate IFN-r producing in the end were verified to be impaired by qPCR and Western blot, due to OVA induced inflammation. IL-27 administration by nasal pre-OVA sensitization could reverse GADD45γ impairment but not STAT1 phosphorylation. So, In low-dose-multiple prevention group, IL-27 inhibits inflammation around bronchial and vascular obviously. In the other hand, IL-27 has little effect on alleviating airway inflammation when used post-OVA sensitization because of already committed Th2 cell resident in the airway. CONCLUSIONS: Our model demonstrated IL-27 resistance when used post-OVA sensitization due to existed Th2- induced STAT1 and GADD45γ downregulation. Low-dose-multiple preventive way improve airway inflammation greatly by reversing GADD45γ expression but not STAT1-Py which indicate intervention time-point is critically important in modulating Th1-Th2 balance when using cytokine strategies. CLINICAL IMPLICATIONS: 1. Cytokine strategy might be a potential way to regulate Th1-Th2 unbalance in asthma. 2. The intervention time point of cytokine will be critical when using this method in vivo. DISCLOSURE: The following authors have nothing to disclose: Zhihong Chen, Xiaoqiong Su, Nian Dong, Kan Xu, Xiangdong Wang No Product/Research Disclosure Information